Arimidex vs Aromasin: Estrogen Control and Dose Differences
Arimidex vs Aromasin
Both lower estrogen production. The useful differences are how they act, food instructions and how a prescription is monitored—not which has the bigger milligram number.
Neither is automatically the better choice for someone using testosterone. There is no reliable milligram-for-milligram swap, and either can lower estrogen too far.
Androgens Aromatase Estrogens
Reversible inhibition of the enzyme.
The body can make new aromatase.
“Irreversible” does not mean estrogen can never rise again.
The practical differences
| Compare | Anastrozole / Arimidex | Exemestane / Aromasin |
|---|---|---|
| Names on the package | Anastrozole / Arimidex | Exemestane / Aromasin |
| Enzyme interaction | Reversible inhibition | Irreversible inactivation of affected enzyme |
| Meaning of clearance | Drug concentration declines | Drug may decline before the enzyme effect ends |
| Food instructions | Label permits with or without food | Label specifies after a meal |
The comparison follows the Arimidex and Aromasin prescribing information. Oncology dosing is not a steroid-cycle protocol.
Dose and frequency: keep the context attached
1 mg daily
Arimidex: oncology label
By mouth, with or without food. Duration follows the cancer treatment plan.
25 mg daily
Aromasin: oncology label
By mouth after a meal. Duration follows the cancer treatment plan.
0.5 mg × 3/week
Selected men on testosterone
Initial anastrozole schedule in one clinic series, adjusted at follow-up. Not a universal TRT dose.
The clinic series used anastrozole for selected men with elevated estradiol. It does not make that amount necessary for everyone on TRT, and the oncology doses above are not TRT instructions. The labels linked above supply their own indication-specific schedules.
Does Aromasin prevent rebound?
“Irreversible” does not mean estrogen can never rise again. The body makes new enzyme, and ongoing androgen exposure still matters. A plasma half-life describes drug concentration, not the full return of hormone production. Exemestane’s enzyme effect can persist while new aromatase is made. Anastrozole’s reversible mechanism also does not promise that every symptom or estradiol result normalizes on a fixed day.
A curve of AI concentration is therefore not a curve of estradiol. Overlaying it with a testosterone curve cannot calculate how much estradiol a particular person will produce.
Can lowering estrogen improve one number but worsen another?
A small, short study in healthy adolescent and young adult males found that exemestane reduced estradiol and raised testosterone. It did not study management of a nonmedical anabolic-steroid cycle or long-term health outcomes. IGF-I did not change, so the study does not support an automatic IGF-I advantage or penalty. Mauras et al., 2003
In a separate one-year trial in older men with low or borderline testosterone, anastrozole raised testosterone but reduced spine bone density relative to placebo. Raising one hormone number did not mean that every health outcome improved. Burnett-Bowie et al., 2009
Switching: what information should go with the prescription?
Write down the exact medicine, previous dose dates, relevant hormone results and symptoms. Ask what clinical outcome is being treated and when it should be reassessed. Do not substitute milligrams between products or infer equivalent exposure from a bioavailability figure taken from a different population.
Food and other medicines can affect product-specific exposure; follow the actual prescription and label. A comparison article cannot replace the instructions for a named product.
Common questions
Is irreversible inhibition permanent? It applies to the enzyme molecules affected, not to every aromatase molecule the body will ever make. It does not mean permanent estrogen suppression.
Does reversible mean harmless if I overshoot? No. Mechanism is not a safety ranking.
Which is better for high estradiol on testosterone? A number alone cannot choose the treatment. Symptoms, the reason for testosterone use, assay and the wider clinical picture matter.
Is low estradiol always better? No. The bone-density trial demonstrates why the goal cannot simply be maximal suppression.
Continue with AI timing for the distinction between a lab schedule and a dosing schedule.
Sources and review notes
Updated October 12, 2026. Official product labels establish the mechanism, food instructions and oncology doses; those doses are not a tested bodybuilding regimen. The selected-men clinic series is observational. The male studies below address different populations and cannot rank these drugs for steroid-cycle management.
- Arimidex prescribing information.
- Aromasin prescribing information.
- Punjani et al., 2021: anastrozole in selected men receiving testosterone.
- Mauras et al., 2003: short-term exemestane study in young males.
- Burnett-Bowie et al., 2009: bone-density findings in older men.
Related compounds & model context
Article citations are linked in the text. Related catalog entries have separate model inputs and source notes, which may include unverified estimates. See our methodology for model assumptions and limitations.